Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |